Avelumab With Decitabine as First Line for AML Treatment of Patients With AML, Who Are Unfit for Intensive Chemotherapy

NCT03395873 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Recent FDA approval of a new drug for the same patient population

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Avelumab

Sponsor

Milton S. Hershey Medical Center

Collaborators

[object Object]